RICHARD MCMULLAN: Open Payments
NPI 1033973359 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 18 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $347 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $102 |
| ABIOMED | 2 | $56 |
| Novartis Pharmaceuticals Corporation | 3 | $51 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| Philips North America LLC | 2 | $41 |
| Amgen Inc. | 2 | $32 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Acist Medical Systems, Inc. | 1 | $15 |
Products named: LEQVIO, CAMZYOS, VERQUVO, REPATHA, Technical Education MRI, LifeVest, Kerendia, CVI Systems.
Industry payments across MS — which companies pay providers there.
